Epigenetics of Meningiomas

Meningiomas account for one-third of all adult central nervous system tumours and are divided into three WHO grades. In contrast to the relatively well characterized genetic alterations, our current understanding of epigenetic modifications involved in the meningioma-genesis and progression is rathe...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2015-01, Vol.2015 (2015), p.1-6
Main Authors: Murnyak, Balazs, Bognar, Laszlo, Klekner, Almos, Hortobagyi, Tibor
Format: Article
Language:English
Subjects:
Biomedical research
Cancer
Cancer therapies
Cell Transformation, Neoplastic - genetics
Colleges & universities
Deoxyribonucleic acid
DNA
DNA methylation
DNA Methylation - genetics
Enzymes
Epigenesis, Genetic
Epigenetic inheritance
Epigenetics
Gene expression
Genetic aspects
Humans
Meningioma
Meningioma - genetics
Meningioma - pathology
MicroRNAs
MicroRNAs - genetics
Neoplasm Recurrence, Local - genetics
Observations
Pathogenesis
Review
Tumorigenesis
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c594t-992aba056132ab509c5efb4b0e6e1f39bdbc751f47510d8b2f2dfcb4bde00fd63
cites cdi_FETCH-LOGICAL-c594t-992aba056132ab509c5efb4b0e6e1f39bdbc751f47510d8b2f2dfcb4bde00fd63
container_end_page 6
container_issue 2015
container_start_page 1
container_title BioMed research international
container_volume 2015
creator Murnyak, Balazs
Bognar, Laszlo
Klekner, Almos
Hortobagyi, Tibor
description Meningiomas account for one-third of all adult central nervous system tumours and are divided into three WHO grades. In contrast to the relatively well characterized genetic alterations, our current understanding of epigenetic modifications involved in the meningioma-genesis and progression is rather incomplete. Contrary to genetic alterations, epigenetic changes do not alter the primary DNA sequence and their reversible nature serves as an excellent basis for prevention and development of novel personalised tumour therapies. Indeed, growing body of evidence suggests that disturbed epigenetic regulation plays a key role in the pathogenesis of meningiomas. Altered DNA methylation, microRNA expression, histone, and chromatin modifications are frequently noted in meningiomas bearing prognostic and therapeutic relevance. In this review we provide an overview on recently identified epigenetic alterations in meningiomas and discuss their role in tumour initiation, progression, and recurrence.
doi_str_mv 10.1155/2015/532451
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4458517</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A458161842</galeid><sourcerecordid>A458161842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c594t-992aba056132ab509c5efb4b0e6e1f39bdbc751f47510d8b2f2dfcb4bde00fd63</originalsourceid><addsrcrecordid>eNqNkc9LHDEUx4MoVdRTbz0UwUuxrObl10wuwrKoFRQv9hwymZfdyGyyney29L83w-p29VJzSB7kwycv70vIZ6DnAFJeMAryQnImJOyQA8ZBjBQI2N3UnO-T45yfaFk1KKrVJ7LPFFCoKnFAvlwtwhQjLoPLJ8mf3GMMcRrS3OYjsudtl_H45TwkP6-vHic_RncPN7eT8d3ISS2WI62ZbSyV5alSSKqdRN-IhqJC8Fw3beMqCV6UjbZ1wzxrvStAi5T6VvFDcrn2LlbNHFuHcdnbziz6MLf9X5NsMG9vYpiZafpthJC1hKoIvr0I-vRrhXlp5iE77DobMa2ygYqC0JpS-D-qNAwwG6yn79CntOpjmUShasUl5Vr8o6a2QxOiT6VFN0jNuLQHCmrBCvV9Tbk-5dyj3_wOqBlyNEOOZp1job9uD2TDvqZWgLM1MAuxtX_Cx2xYEPR2C5ayFjV_BiuKq0w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1686350394</pqid></control><display><type>article</type><title>Epigenetics of Meningiomas</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content (ProQuest)</source><creator>Murnyak, Balazs ; Bognar, Laszlo ; Klekner, Almos ; Hortobagyi, Tibor</creator><contributor>Barresi, Valeria</contributor><creatorcontrib>Murnyak, Balazs ; Bognar, Laszlo ; Klekner, Almos ; Hortobagyi, Tibor ; Barresi, Valeria</creatorcontrib><description>Meningiomas account for one-third of all adult central nervous system tumours and are divided into three WHO grades. In contrast to the relatively well characterized genetic alterations, our current understanding of epigenetic modifications involved in the meningioma-genesis and progression is rather incomplete. Contrary to genetic alterations, epigenetic changes do not alter the primary DNA sequence and their reversible nature serves as an excellent basis for prevention and development of novel personalised tumour therapies. Indeed, growing body of evidence suggests that disturbed epigenetic regulation plays a key role in the pathogenesis of meningiomas. Altered DNA methylation, microRNA expression, histone, and chromatin modifications are frequently noted in meningiomas bearing prognostic and therapeutic relevance. In this review we provide an overview on recently identified epigenetic alterations in meningiomas and discuss their role in tumour initiation, progression, and recurrence.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2015/532451</identifier><identifier>PMID: 26101774</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Biomedical research ; Cancer ; Cancer therapies ; Cell Transformation, Neoplastic - genetics ; Colleges &amp; universities ; Deoxyribonucleic acid ; DNA ; DNA methylation ; DNA Methylation - genetics ; Enzymes ; Epigenesis, Genetic ; Epigenetic inheritance ; Epigenetics ; Gene expression ; Genetic aspects ; Humans ; Meningioma ; Meningioma - genetics ; Meningioma - pathology ; MicroRNAs ; MicroRNAs - genetics ; Neoplasm Recurrence, Local - genetics ; Observations ; Pathogenesis ; Review ; Tumorigenesis ; Tumors</subject><ispartof>BioMed research international, 2015-01, Vol.2015 (2015), p.1-6</ispartof><rights>Copyright © 2015 Balázs Murnyák et al.</rights><rights>COPYRIGHT 2015 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2015 Balazs Murnyak et al. Balazs Murnyak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2015 Balázs Murnyák et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c594t-992aba056132ab509c5efb4b0e6e1f39bdbc751f47510d8b2f2dfcb4bde00fd63</citedby><cites>FETCH-LOGICAL-c594t-992aba056132ab509c5efb4b0e6e1f39bdbc751f47510d8b2f2dfcb4bde00fd63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1686350394/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1686350394?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26101774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Barresi, Valeria</contributor><creatorcontrib>Murnyak, Balazs</creatorcontrib><creatorcontrib>Bognar, Laszlo</creatorcontrib><creatorcontrib>Klekner, Almos</creatorcontrib><creatorcontrib>Hortobagyi, Tibor</creatorcontrib><title>Epigenetics of Meningiomas</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Meningiomas account for one-third of all adult central nervous system tumours and are divided into three WHO grades. In contrast to the relatively well characterized genetic alterations, our current understanding of epigenetic modifications involved in the meningioma-genesis and progression is rather incomplete. Contrary to genetic alterations, epigenetic changes do not alter the primary DNA sequence and their reversible nature serves as an excellent basis for prevention and development of novel personalised tumour therapies. Indeed, growing body of evidence suggests that disturbed epigenetic regulation plays a key role in the pathogenesis of meningiomas. Altered DNA methylation, microRNA expression, histone, and chromatin modifications are frequently noted in meningiomas bearing prognostic and therapeutic relevance. In this review we provide an overview on recently identified epigenetic alterations in meningiomas and discuss their role in tumour initiation, progression, and recurrence.</description><subject>Biomedical research</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Colleges &amp; universities</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA methylation</subject><subject>DNA Methylation - genetics</subject><subject>Enzymes</subject><subject>Epigenesis, Genetic</subject><subject>Epigenetic inheritance</subject><subject>Epigenetics</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Meningioma</subject><subject>Meningioma - genetics</subject><subject>Meningioma - pathology</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>Neoplasm Recurrence, Local - genetics</subject><subject>Observations</subject><subject>Pathogenesis</subject><subject>Review</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkc9LHDEUx4MoVdRTbz0UwUuxrObl10wuwrKoFRQv9hwymZfdyGyyney29L83w-p29VJzSB7kwycv70vIZ6DnAFJeMAryQnImJOyQA8ZBjBQI2N3UnO-T45yfaFk1KKrVJ7LPFFCoKnFAvlwtwhQjLoPLJ8mf3GMMcRrS3OYjsudtl_H45TwkP6-vHic_RncPN7eT8d3ISS2WI62ZbSyV5alSSKqdRN-IhqJC8Fw3beMqCV6UjbZ1wzxrvStAi5T6VvFDcrn2LlbNHFuHcdnbziz6MLf9X5NsMG9vYpiZafpthJC1hKoIvr0I-vRrhXlp5iE77DobMa2ygYqC0JpS-D-qNAwwG6yn79CntOpjmUShasUl5Vr8o6a2QxOiT6VFN0jNuLQHCmrBCvV9Tbk-5dyj3_wOqBlyNEOOZp1job9uD2TDvqZWgLM1MAuxtX_Cx2xYEPR2C5ayFjV_BiuKq0w</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Murnyak, Balazs</creator><creator>Bognar, Laszlo</creator><creator>Klekner, Almos</creator><creator>Hortobagyi, Tibor</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TM</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Epigenetics of Meningiomas</title><author>Murnyak, Balazs ; Bognar, Laszlo ; Klekner, Almos ; Hortobagyi, Tibor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c594t-992aba056132ab509c5efb4b0e6e1f39bdbc751f47510d8b2f2dfcb4bde00fd63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biomedical research</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Colleges &amp; universities</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA methylation</topic><topic>DNA Methylation - genetics</topic><topic>Enzymes</topic><topic>Epigenesis, Genetic</topic><topic>Epigenetic inheritance</topic><topic>Epigenetics</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Meningioma</topic><topic>Meningioma - genetics</topic><topic>Meningioma - pathology</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>Neoplasm Recurrence, Local - genetics</topic><topic>Observations</topic><topic>Pathogenesis</topic><topic>Review</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murnyak, Balazs</creatorcontrib><creatorcontrib>Bognar, Laszlo</creatorcontrib><creatorcontrib>Klekner, Almos</creatorcontrib><creatorcontrib>Hortobagyi, Tibor</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Nucleic Acids Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murnyak, Balazs</au><au>Bognar, Laszlo</au><au>Klekner, Almos</au><au>Hortobagyi, Tibor</au><au>Barresi, Valeria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenetics of Meningiomas</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>2015</volume><issue>2015</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Meningiomas account for one-third of all adult central nervous system tumours and are divided into three WHO grades. In contrast to the relatively well characterized genetic alterations, our current understanding of epigenetic modifications involved in the meningioma-genesis and progression is rather incomplete. Contrary to genetic alterations, epigenetic changes do not alter the primary DNA sequence and their reversible nature serves as an excellent basis for prevention and development of novel personalised tumour therapies. Indeed, growing body of evidence suggests that disturbed epigenetic regulation plays a key role in the pathogenesis of meningiomas. Altered DNA methylation, microRNA expression, histone, and chromatin modifications are frequently noted in meningiomas bearing prognostic and therapeutic relevance. In this review we provide an overview on recently identified epigenetic alterations in meningiomas and discuss their role in tumour initiation, progression, and recurrence.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>26101774</pmid><doi>10.1155/2015/532451</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2015-01, Vol.2015 (2015), p.1-6
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4458517
source Wiley Online Library Open Access; Publicly Available Content (ProQuest)
subjects Biomedical research
Cancer
Cancer therapies
Cell Transformation, Neoplastic - genetics
Colleges & universities
Deoxyribonucleic acid
DNA
DNA methylation
DNA Methylation - genetics
Enzymes
Epigenesis, Genetic
Epigenetic inheritance
Epigenetics
Gene expression
Genetic aspects
Humans
Meningioma
Meningioma - genetics
Meningioma - pathology
MicroRNAs
MicroRNAs - genetics
Neoplasm Recurrence, Local - genetics
Observations
Pathogenesis
Review
Tumorigenesis
Tumors
title Epigenetics of Meningiomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A14%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenetics%20of%20Meningiomas&rft.jtitle=BioMed%20research%20international&rft.au=Murnyak,%20Balazs&rft.date=2015-01-01&rft.volume=2015&rft.issue=2015&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2015/532451&rft_dat=%3Cgale_pubme%3EA458161842%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c594t-992aba056132ab509c5efb4b0e6e1f39bdbc751f47510d8b2f2dfcb4bde00fd63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1686350394&rft_id=info:pmid/26101774&rft_galeid=A458161842&rfr_iscdi=true